Last Name


John Somberg to Cardiovascular Agents

This is a "connection" page, showing publications John Somberg has written about Cardiovascular Agents.

Connection Strength
  1. Somberg J. Angiotensin-Neprilysin Combinations Marketing Poly or Therapeutic Optimization. Am J Ther. 2015 Sep-Oct; 22(5):321.
    View in: PubMed
    Score: 0.717
  2. Ranade VV, Somberg JC. Chiral cardiovascular drugs: an overview. Am J Ther. 2005 Sep-Oct; 12(5):439-59.
    View in: PubMed
    Score: 0.359
  3. Somberg JC, Molnar J. The pharmacologic treatment of heart failure. Am J Ther. 2004 Nov-Dec; 11(6):480-8.
    View in: PubMed
    Score: 0.338
  4. Ranade V, Somberg JC. Rapid determination of partition coefficients between n-octanol/water for cardiovascular therapies. Am J Ther. 2002 Jan-Feb; 9(1):19-24.
    View in: PubMed
    Score: 0.278
  5. Somberg JC. International symposium on drug development. Am J Ther. 1999 Sep; 6(5):289.
    View in: PubMed
    Score: 0.237
  6. Somberg JC. Have we maxed out on new therapies. Am J Ther. 2011 Mar-Apr; 18(2):91.
    View in: PubMed
    Score: 0.131
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.